EUVIMEDEUVIMED entdecken
Open Access

Introduction of Procalcitonin Testing and Antibiotic Utilization for Acute Exacerbations of Chronic Obstructive Pulmonary Disease

Robert J Ulrich iD, Daniel McClung, Bonnie R Wang, Spencer Winters, Scott A Flanders, Krishna Rao

Infectious Diseases: Research and Treatment · 2019

DOI: 10.1177/1178633719852626 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Infectious Diseases: Research and Treatment, 2019. Verfasst von Robert J Ulrich und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, School of Medicine, University of Michigan, Ann Arbor, MI, USA. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NCATS NIH HHS, claude pepper older americans independence center, wake forest school of medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The majority of acute exacerbations of chronic obstructive pulmonary disease (AECOPD) are triggered by nonbacterial causes, yet most patients receive antibiotics. Treatment guided by procalcitonin (PCT), a sensitive biomarker of bacterial infection, safely decreases antibiotic use in many controlled trials. We evaluated PCT implementation for inpatients with AECOPD at a large academic hospital.

Methods

All patients admitted for AECOPD during the first 6 months of PCT-guided therapy were eligible for inclusion in this retrospective cohort study. Patients with PCT performed were compared with those without PCT. The primary outcome was antibiotic days of therapy (DOT). Secondary outcomes included 30-day readmission and mortality.

Results

Of the 238 AECOPD admissions, 73 (31%) had PCT performed. Procalcitonin-tested patients were more likely to meet systemic inflammatory response syndrome (SIRS) criteria, require intensive care unit (ICU)-level care, and have a longer length of stay (LOS) compared with those without PCT. Even after adjustment for these factors, PCT-tested patients received more inpatient DOT and there was no difference in total DOT. However, a low PCT value (

Schlagwörter

Stichwörter der Autor:innen

COPD exacerbationantibioticsprocalcitoninrespiratory infection

Autor:innen und Institutionen

  • Department of Internal Medicine, School of Medicine, University of Michigan, Ann Arbor, MI, USA.
  • Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, MI, USA.
  • Division of Infectious Diseases and Immunology, NYU School of Medicine, New York, NY, USA.
  • Division of Infectious Diseases, School of Medicine, University of Michigan, Ann Arbor, MI, USA.
  • Division of Pulmonary and Critical Care, School of Medicine, University of Michigan, Ann Arbor, MI, USA.
  • Division of Pulmonary, Allergy and Critical Care Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.

ORCID-Profile: Robert J Ulrich

Förderung

  • NIA NIH HHS
  • NCATS NIH HHS
  • claude pepper older americans independence center, wake forest school of medicine
  • michigan institute for clinical and health research
  • blue cross blue shield of michigan foundation
  • agency for healthcare research and quality
  • wiley

Zitieren

APA

Ulrich, R. J., McClung, D., Wang, B. R., Winters, S., Flanders, S. A., & Rao, K. (2019). Introduction of Procalcitonin Testing and Antibiotic Utilization for Acute Exacerbations of Chronic Obstructive Pulmonary Disease. Infectious Diseases: Research and Treatment. https://doi.org/10.1177/1178633719852626

Vancouver

Ulrich RJ, McClung D, Wang BR, Winters S, Flanders SA, Rao K. Introduction of Procalcitonin Testing and Antibiotic Utilization for Acute Exacerbations of Chronic Obstructive Pulmonary Disease. Infectious Diseases: Research and Treatment. 2019. doi:10.1177/1178633719852626

BibTeX
@article{Ulrich2019,
  author = {Ulrich, Robert J and McClung, Daniel and Wang, Bonnie R and Winters, Spencer and Flanders, Scott A and Rao, Krishna},
  title = {Introduction of Procalcitonin Testing and Antibiotic Utilization for Acute Exacerbations of Chronic Obstructive Pulmonary Disease},
  journal = {Infectious Diseases: Research and Treatment},
  year = {2019},
  doi = {10.1177/1178633719852626}
}
Kostenlos starten →